Compound Detail
CHEMBL5091825
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5091825 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | LFOXSTPPEXOYIT-UHFFFAOYSA-N |
4
Targets
9
Activities
1
Assay Types
28
PK Parameters
20
Publications
0
Known Names
Molecular Properties
485.3
MW (Da)
1.43
ALogP
11
HBA
4
HBD
155.7
PSA (Ų)
0.11
QED
1
Ro5 Violations
10
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 9 meas. best 8.67
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Indoleamine 2,3-dioxygenase 1 CHEMBL4685 | IC50 | 8.67 | 8.11 | 2.2 | 4 |
| Indoleamine 2,3-dioxygenase 2 CHEMBL3627587 | IC50 | 6.84 | 6.84 | 144.0 | 2 |
| HCT-116 CHEMBL394 | IC50 | 4.25 | 4.25 | 56130.0 | 1 |
| CT26 CHEMBL613866 | IC50 | 4.21 | 4.21 | 61960.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 3053.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 3040.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 3640.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 3950.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 27.5 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 30.1 | mL.min-1.g-1 | Homo sapiens |
| CL | 36.0 | mL.min-1.g-1 | Macaca mulatta |
| CL | 245.0 | mL.min-1.g-1 | Canis lupus familiaris |
| CL | 65.3 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 32.2 | mL.min-1.g-1 | Mus musculus |
| CL | 27.5 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 2149.32 | nM | Rattus norvegicus |
| F | 12.0 | % | Rattus norvegicus |
| F | 12.9 | % | Rattus norvegicus |
| Fu | 0.0411 | - | Homo sapiens |
| Fu | 0.0763 | - | Macaca mulatta |
| Fu | 0.0498 | - | Canis lupus familiaris |
| Fu | 0.0672 | - | Rattus norvegicus |
| Fu | 0.0968 | - | Mus musculus |
| T1/2 | 0.61 | hr | Rattus norvegicus |
| T1/2 | 1.9 | hr | Rattus norvegicus |
| T1/2 | 0.7683 | hr | Homo sapiens |
| T1/2 | 0.6433 | hr | Macaca mulatta |
| T1/2 | 0.09433 | hr | Canis lupus familiaris |
| T1/2 | 0.3533 | hr | Rattus norvegicus |
| T1/2 | 0.72 | hr | Mus musculus |
| Tmax | 1.3 | hr | Rattus norvegicus |
| Vd | 0.88 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Indoleamine 2,3-dioxygenase 1 | IC50 | = | 2.16 | nM | 8.67 | Inhibition of IDO1 in IFNgamma-stimulated human HeLa cells assessed as reduction... | 34854662 |
| Indoleamine 2,3-dioxygenase 1 | IC50 | = | 2.16 | nM | 8.67 | Inhibition of IDO1 in human HeLa cells | 35696861 |
| Indoleamine 2,3-dioxygenase 1 | IC50 | = | 28.0 | nM | 7.55 | Inhibition of IDO1 (unknown origin) assessed as reduction in kynurenine formatio... | 34854662 |
| Indoleamine 2,3-dioxygenase 1 | IC50 | = | 28.0 | nM | 7.55 | Inhibition of human IDO1 | 35952367 |
| Indoleamine 2,3-dioxygenase 2 | IC50 | = | 144.0 | nM | 6.84 | Inhibition of IDO2 (unknown origin) assessed as reduction in kynurenine formatio... | 34854662 |
| Indoleamine 2,3-dioxygenase 2 | IC50 | = | 144.0 | nM | 6.84 | Inhibition of human IDO2 | 35952367 |
| HCT-116 | IC50 | = | 56130.0 | nM | 4.25 | Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability... | 34854662 |
| CT26 | IC50 | = | 61960.0 | nM | 4.21 | Cytotoxicity against mouse CT26 cells assessed as reduction in cell viability by... | 34854662 |
Literature References
Data from ChEMBL 36 via Core Engine